
    
      To conduct the relative bioavailability study of a single dose and multiple doses of imatinib
      mesylate capsule(Jiangsu Chia-Tai Tianqing Pharmacy Co. Ltd.) versus Glivec (Novartis Pharma
      Stein AG) and compare the bioequivalence and pharmacokinetics of the two products in 20
      patients with chronic myeloid leukemia.
    
  